A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
NCT06710379
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
ADRX-0405
Sponsor
Adcentrx Therapeutics